- Home
- NNVC vs SNES Comparison
NNVC vs SNES Comparison
Compare NNVC & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- SNES
- Stock Information
- Founded
- NNVC 2005
- SNES 2004
- Country
- NNVC United States
- SNES United States
- Employees
- NNVC N/A
- SNES N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- NNVC Health Care
- SNES Industrials
- Exchange
- NNVC Nasdaq
- SNES Nasdaq
- Market Cap
- NNVC 22.5M
- SNES 21.0M
- IPO Year
- NNVC N/A
- SNES 2016
- Fundamental
- Price
- NNVC $1.68
- SNES $5.65
- Analyst Decision
- NNVC
- SNES Strong Buy
- Analyst Count
- NNVC 0
- SNES 1
- Target Price
- NNVC N/A
- SNES $10.00
- AVG Volume (30 Days)
- NNVC 334.4K
- SNES 219.4K
- Earning Date
- NNVC 05-15-2025
- SNES 08-07-2025
- Dividend Yield
- NNVC N/A
- SNES N/A
- EPS Growth
- NNVC N/A
- SNES N/A
- EPS
- NNVC N/A
- SNES N/A
- Revenue
- NNVC N/A
- SNES $1,927,000.00
- Revenue This Year
- NNVC N/A
- SNES $130.53
- Revenue Next Year
- NNVC N/A
- SNES $80.00
- P/E Ratio
- NNVC N/A
- SNES N/A
- Revenue Growth
- NNVC N/A
- SNES 40.15
- 52 Week Low
- NNVC $0.94
- SNES $1.30
- 52 Week High
- NNVC $2.50
- SNES $5.99
- Technical
- Relative Strength Index (RSI)
- NNVC 60.67
- SNES 67.74
- Support Level
- NNVC $1.54
- SNES $4.31
- Resistance Level
- NNVC $1.79
- SNES $5.99
- Average True Range (ATR)
- NNVC 0.10
- SNES 0.36
- MACD
- NNVC 0.02
- SNES 0.02
- Stochastic Oscillator
- NNVC 75.56
- SNES 79.46
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.